CIRM Board Approves Two Additional COVID-19 Projects

Dr. Vaithilingaraja Arumugaswami (left) and Dr. Song Li (right), UCLA Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two additional projects as part of the $5 million in emergency funding for COVID-19 related projects. This brings the number of projects CIRM is supporting to 11, including two clinical trials. The Board awarded $349,999 … Continue reading CIRM Board Approves Two Additional COVID-19 Projects

Stem Cell Agency Board Approves Three More Projects Targeting COVID-19

Dr. Jianhua Yu (left), Dr. Helen Blau (center), and Dr. Albert Wong (right) The COVID-19 virus targets many different parts of the body, often with deadly or life-threatening consequences. This past Friday the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs taking different approaches to battling … Continue reading Stem Cell Agency Board Approves Three More Projects Targeting COVID-19

Treatment for heart failure shows promising results for COVID-19 patients

Dr. Linda Marbán To help with the coronavirus pandemic, many scientists are repurposing previously developed approaches or treatments to see if they can be used to treat patients with COVID-19. Capricor Therapeutics, lead by Dr. Linda Marbán, is using cardiosphere derived cells (CDCs), which are stem cells derived from heart tissue, to treat critically ill … Continue reading Treatment for heart failure shows promising results for COVID-19 patients

Two UCLA scientists receive CIRM funding for discovery research for COVID-19

Dr. Brigitte Gomperts (left) and Dr. Gay Crooks (right), UCLAImage Credit: UCLA Broad Stem Cell Center This past Friday, the CIRM Board approved funding for its first clinical study for COVID-19. In addition to this, the Board also approved two discovery stage research projects, which support promising new technologies that could be translated to enable … Continue reading Two UCLA scientists receive CIRM funding for discovery research for COVID-19

CIRM Board Funds its First Clinical Study for COVID-19

Dr. John Zaia, City of hope Today the governing Board of the California Institute for Regenerative Medicine (CIRM) continued its commitment to help with the coronavirus pandemic by awarding $749,999 to Dr. John Zaia at City of Hope.  He will be conducting a clinical study to administer blood plasma from recovered COVID-19 patients to treat … Continue reading CIRM Board Funds its First Clinical Study for COVID-19

Study shows that exercise rejuvenates muscle stem cells of old mice

Dr. Thomas Rando, Stanford University While we're all at home and practicing social distancing during this global pandemic, it has become a challenge to get in daily exercise. Aside from outward physical appearance, what other benefits does exercise hold? Dr. Thomas Rando and his team at Stanford University explored this question in more detail in … Continue reading Study shows that exercise rejuvenates muscle stem cells of old mice

CIRM Board Expands COVID-19 Efforts

Coronavirus particles, illustration. Courtesy KTSDesign/Science Photo Library This past Friday, the governing Board of the California Institute for Regenerative Medicine (CIRM) expanded the eligibility criteria for COVID-19 related projects to develop new treatments against the virus.  Just two weeks ago, the Board approved $5 million in emergency funding for COVID-19 research. One major addition is allowing research related … Continue reading CIRM Board Expands COVID-19 Efforts

Cashing in on COVID-19

Coronavirus particles, illustration. Courtesy KTSDesign/Science Photo Library As the coronavirus pandemic continues to spread, one of the few bright spots is how many researchers are stepping up and trying to find new ways to tackle it, to treat it and hopefully even cure it. Unfortunately, there are also those who are simply trying to cash … Continue reading Cashing in on COVID-19

From bench to bedside – CIRM plays a vital role in accelerating science

Dr. Maria T. Millan, President & CEO of CIRM The field of stem cell research and regenerative medicine has exploded in the last few years with new approaches to treat a wide array of diseases. Although these therapies are quite promising, they face many challenges in trying to bring them from the laboratory and into … Continue reading From bench to bedside – CIRM plays a vital role in accelerating science

Ask the Stem Cell Team About Autism

On March 19th we held a special Facebook Live "Ask the Stem Cell Team About Autism" event. We were fortunate enough to have two great experts - Dr. Alysson Muotri from UC San Diego, and CIRM's own Dr. Kelly Shepard. As always there is a lot of ground to cover in under one hour and … Continue reading Ask the Stem Cell Team About Autism